This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2003 Jul 9;290(2):193; author reply 193.

doi: 10.1001/jama.290.2.193-b.

Aplastic anemia and immunosuppression

Stephen M Nagy Jr, John J Fisher

PMID: 12851270
DOI: 10.1001/jama.290.2.193-b

Comment

Aplastic anemia and immunosuppression

Stephen M Nagy Jr et al. JAMA. 2003.

. 2003 Jul 9;290(2):193; author reply 193.

doi: 10.1001/jama.290.2.193-b.

Authors

Stephen M Nagy Jr, John J Fisher

PMID: 12851270
DOI: 10.1001/jama.290.2.193-b

No abstract available

PubMed Disclaimer

Comment on

Antithymocyte globulin and cyclosporine for severe aplastic anemia: association between hematologic response and long-term outcome.
Rosenfeld S, Follmann D, Nunez O, Young NS. Rosenfeld S, et al. JAMA. 2003 Mar 5;289(9):1130-5. doi: 10.1001/jama.289.9.1130. JAMA. 2003. PMID: 12622583 Clinical Trial.

Similar articles

[Immune-mediated pathogenesis and management of pediatric aplastic anemia].
Huang YL, Huang SL. Huang YL, et al. Zhonghua Er Ke Za Zhi. 2006 Feb;44(2):153-5. Zhonghua Er Ke Za Zhi. 2006. PMID: 16624043 Review. Chinese. No abstract available.
[The use of allogeneic bone marrow transplantation and immunosuppressive therapy in the treatment of patients with acquired aplastic anemia].
Ganapiev AA, Golubovskaia IK, Zalialov IuR, Estrina MA, Afanas'ev BV. Ganapiev AA, et al. Ter Arkh. 2010;82(7):48-52. Ter Arkh. 2010. PMID: 20853609 Clinical Trial. Russian.
High-dose cyclophosphamide in the treatment of severe aplastic anemia in children.
Jaime-Pérez JC, González-Llano O, Gómez-Almaguer D. Jaime-Pérez JC, et al. Am J Hematol. 2001 Jan;66(1):71. doi: 10.1002/1096-8652(200101)66:1<71::AID-AJH1019>3.0.CO;2-D. Am J Hematol. 2001. PMID: 11426504 No abstract available.
HLA-DRB1*15 and pediatric aplastic anemia.
Oguz FS, Yalman N, Diler AS, Oguz R, Anak S, Dorak MT. Oguz FS, et al. Haematologica. 2002 Jul;87(7):772-4. Haematologica. 2002. PMID: 12091130
Immunosuppressive therapy for transplant-ineligible aplastic anemia patients.
Schrezenmeier H, Körper S, Höchsmann B. Schrezenmeier H, et al. Expert Rev Hematol. 2015 Feb;8(1):89-99. doi: 10.1586/17474086.2015.978759. Expert Rev Hematol. 2015. PMID: 25572607 Review.

See all similar articles

Cited by

The role of the Th1 transcription factor T-bet in a mouse model of immune-mediated bone-marrow failure.
Tang Y, Desierto MJ, Chen J, Young NS. Tang Y, et al. Blood. 2010 Jan 21;115(3):541-8. doi: 10.1182/blood-2009-03-211383. Epub 2009 Nov 10. Blood. 2010. PMID: 19903901 Free PMC article.
MHC class II upregulation and colocalization with Fas in experimental models of immune-mediated bone marrow failure.
Erie AJ, Samsel L, Takaku T, Desierto MJ, Keyvanfar K, McCoy JP, Young NS, Chen J. Erie AJ, et al. Exp Hematol. 2011 Aug;39(8):837-49. doi: 10.1016/j.exphem.2011.05.005. Epub 2011 May 13. Exp Hematol. 2011. PMID: 21635935 Free PMC article.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Silverchair Information Systems
Medical
- MedlinePlus Health Information